S&P Futures
4,449.25 -25.50 (-0.57%) Dow Futures
34,516.00 -100.00 (-0.29%) Nasdaq Futures
14,704.00 -137.00 (-0.92%) Russell 2000 Futures
2,014.40 -6.80 (-0.34%) Crude Oil
84.35 -1.20 (-1.40%) Gold
1,835.60 -7.00 (-0.38%)
Protagonist Therapeutics, Inc. (PTGX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 34.27 |
| Open | 34.87 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's Range | 31.63 - 35.54 |
| 52 Week Range | 12.80 - 50.54 |
| Volume | |
| Avg. Volume | 585,070 |
| Market Cap | 1.518B |
| Beta (5Y Monthly) | 2.17 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.43 |
| Earnings Date | Mar 08, 2022 - Mar 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 53.88 |
- Barrons.com
5 Biotech Stocks That Are Bucking the Selloff
Biotech investors still like BioCryst, Protagonist, Prometheus Biosciences, Rani, and Emergent BioSolutions. All sported recent double-digit gains despite the sector slump.
- Insider Monkey
Protagonist Therapeutics, Inc. (PTGX) Fell Out Of Favor With Hedge Funds
In this article we will check out the progression of hedge fund sentiment towards Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]
- PR Newswire
/C O R R E C T I O N -- Protagonist Therapeutics, Inc./
Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11 at 2:15 p.m. EST.
